← Back to directory

Janusz Rybakowski

Researcher Next ID · RN-041248

Researcher · Medicine

Poznan University of Medical Sciences

Poznan, Poland

Accepting doctoral researchersFunding unknown
Works count
911
Citation count
21,160
H-index
70
i10-index
321

Research interests

Medicine
Neuroscience
Bipolar Disorder and Treatment
Schizophrenia research and treatment
Tryptophan and brain disorders
Treatment of Major Depression
Electroconvulsive Therapy Studies

Publications

  • Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment

    Therapeutic Advances in Psychopharmacology · 2018 · 10.1177/2045125318759461

  • Wilson disease

    Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0018-3

  • Childhood trauma in mood disorders: Neurobiological mechanisms and implications for treatment

    Pharmacological Reports · 2018 · 10.1016/j.pharep.2018.10.004

  • Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry · 2018 · 10.1016/s2215-0366(18)30252-9

  • Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review

    Schizophrenia Research · 2017 · 10.1016/j.schres.2017.04.015

  • Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    Molecular Psychiatry · 2017 · https://doi.org/10.1038/mp.2017.73

  • Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder

    JAMA Psychiatry · 2017 · 10.1001/jamapsychiatry.2017.3433

  • Relationship of suicide rates to economic variables in Europe: 2000–2011

    The British Journal of Psychiatry · 2014 · https://doi.org/10.1192/bjp.bp.114.147454

  • Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport

    Acta Psychiatrica Scandinavica · 2014 · 10.1111/acps.12305

  • Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report

    PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0065636

  • Stratified medicine for mental disorders

    European Neuropsychopharmacology · 2013 · 10.1016/j.euroneuro.2013.09.010

  • The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

    American Journal of Psychiatry · 2013 · https://doi.org/10.1176/appi.ajp.2013.13020185

  • Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response

    Psychological Medicine · 2013 · 10.1017/s0033291713001165

  • Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

    The Journal of Clinical Psychiatry · 2010 · 10.4088/jcp.09m05347blu

  • The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium Treatment

    Neuropsychobiology · 2010 · 10.1159/000314708

  • Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study

    Schizophrenia Research · 2009 · 10.1016/j.schres.2009.09.022

  • Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

    American Journal of Psychiatry · 2009 · https://doi.org/10.1176/appi.ajp.2008.08060806

  • Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

    The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60486-9

  • Changes in Acute-Phase Proteins during Lithium Potentiation of Antidepressants in Refractory Depression

    Neuropsychobiology · 2008 · 10.1159/000119332

  • Polymorphism of the brain‐derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients

    Bipolar Disorders · 2003 · 10.1046/j.1399-5618.2003.00071.x

  • CROSS-CULTURAL EVALUATION OF TWO DRINKING ASSESSMENT INSTRUMENTS: ALCOHOL TIMELINE FOLLOWBACK AND INVENTORY OF DRINKING SITUATIONS

    Substance Use & Misuse · 2001 · https://doi.org/10.1081/ja-100102628

  • Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar

    Bipolar Disorders · 2001 · 10.1034/j.1399-5618.2001.030207.x

  • The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

    Journal of Psychiatric Research · 1999 · 10.1016/s0022-3956(99)00014-x

  • Indicators of immune activation in major depression

    Psychiatry Research · 1996 · 10.1016/s0165-1781(96)02783-7

  • Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine

    Annals of the New York Academy of Sciences · 1995 · 10.1111/j.1749-6632.1995.tb32372.x

  • [Clinical pharmacokinetics of carbamazepine].

    PubMed · 1990

Current projects

    No projects listed.